These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21045601)

  • 1. Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes.
    Montaner JS; Wood E; Kerr T; Lima V; Barrios R; Shannon K; Harrigan R; Hogg R
    J Acquir Immune Defic Syndr; 2010 Dec; 55 Suppl 1():S5-9. PubMed ID: 21045601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting.
    Montaner JS; Lima VD; Harrigan PR; Lourenço L; Yip B; Nosyk B; Wood E; Kerr T; Shannon K; Moore D; Hogg RS; Barrios R; Gilbert M; Krajden M; Gustafson R; Daly P; Kendall P
    PLoS One; 2014; 9(2):e87872. PubMed ID: 24533061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage of highly active antiretroviral therapy among postpartum women in Malawi.
    Kumwenda J; Matchere F; Mataya R; Chen S; Mipando L; Li Q; Kumwenda NI; Taha TE
    Int J STD AIDS; 2011 Jul; 22(7):368-72. PubMed ID: 21729953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs.
    Nosyk B; Min JE; Evans E; Li L; Liu L; Lima VD; Wood E; Montaner JS
    Clin Infect Dis; 2015 Oct; 61(7):1157-65. PubMed ID: 26113656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential impact of drugs of abuse on mother-to-child transmission (MTCT) of HIV in the era of highly active antiretroviral therapy (HAART).
    Purohit V; Rapaka RS; Schnur P; Shurtleff D
    Life Sci; 2011 May; 88(21-22):909-16. PubMed ID: 21477599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
    Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
    Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social and structural determinants of HAART access and adherence among injection drug users.
    Krüsi A; Wood E; Montaner J; Kerr T
    Int J Drug Policy; 2010 Jan; 21(1):4-9. PubMed ID: 19747811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men.
    Zaric GS; Bayoumi AM; Brandeau ML; Owens DK
    Med Decis Making; 2008; 28(3):359-76. PubMed ID: 18349433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.
    Knowlton AR; Arnsten JH; Eldred LJ; Wilkinson JD; Shade SB; Bohnert AS; Yang C; Wissow LS; Purcell DW
    AIDS Patient Care STDS; 2010 Jul; 24(7):421-8. PubMed ID: 20578910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unrealized potential of addiction science in curbing the HIV epidemic.
    Volkow ND; Baler RD; Normand JL
    Curr HIV Res; 2011 Sep; 9(6):393-5. PubMed ID: 21999774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV treatment as prevention among injection drug users.
    Wood E; Milloy MJ; Montaner JS
    Curr Opin HIV AIDS; 2012 Mar; 7(2):151-6. PubMed ID: 22227587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.
    Tegger MK; Crane HM; Tapia KA; Uldall KK; Holte SE; Kitahata MM
    AIDS Patient Care STDS; 2008 Mar; 22(3):233-43. PubMed ID: 18290749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
    Wood E; Hogg RS; Lima VD; Kerr T; Yip B; Marshall BD; Montaner JS
    JAMA; 2008 Aug; 300(5):550-4. PubMed ID: 18677027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mother-to-child transmission of HIV-1 in the era prior to the availability of combination antiretroviral therapy: the role of drugs of abuse.
    Van Dyke RB
    Life Sci; 2011 May; 88(21-22):922-5. PubMed ID: 21439978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
    Krentz HB; Kliewer G; Gill MJ
    HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
    AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.
    Mimiaga MJ; Safren SA; Dvoryak S; Reisner SL; Needle R; Woody G
    AIDS Care; 2010 Nov; 22(11):1305-13. PubMed ID: 20640954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.